Disappointingly, given the two and a half years invested into this evidence-gathering project, the output is a very weak and confused document rather than something that is “potent, powerful and purposeful,” as has been claimed.
The report itself is compromised, at its very outset, by the disclaimer which blandly states
Free Trial
Register for free to keep reading.
To continue reading this article and unlock full access to GRIP, register now. You’ll enjoy free access to all content until our subscription service launches in early 2026.
- Unlimited access to industry insights
- Stay on top of key rules and regulatory changes with our Rules Navigator
- Ad-free experience with no distractions
- Regular podcasts from trusted external experts
- Fresh compliance and regulatory content every day
